Zhang Qian, Thamer Mae, Kshirsagar Onkar, Zhang Yi
Medical Technology and Practice Patterns Institute, Bethesda, Maryland, USA.
Kidney Int Rep. 2016 Dec 20;2(3):350-358. doi: 10.1016/j.ekir.2016.12.004. eCollection 2017 May.
The End Stage Renal Disease (ESRD) Prospective Payment System (PPS), implemented by the Centers for Medicare and Medicaid Services in January 2011, encouraged use of peritoneal dialysis (PD) through various financial incentives. Our goal was to determine whether PPS effectively increased PD use in incident dialysis patients.
Our study used the United States Renal Data System (USRDS) to identify 430,927 adult patients who initiated dialysis between 2009 and 2012. The interrupted time series method was used to evaluate the association Centers for Medicare and Medicaid Services of PPS with PD use at dialysis initiation. We further stratified by patient demographics, predialysis care, and facility chain and profit status.
Interrupted time series analysis indicated PPS was associated with increased PD use in the 2-year period after PPS (change in slope = 0.04, < 0.0001), although there was no immediate change in the level of PD use at the beginning of PPS ( = 0.512). Stratified analyses indicated PPS led to increased PD use across all age, race, and sex groups ( < 0.05) although marginally among females ( = 0.09). Notably, small dialysis organizations and nonprofit organizations appeared to increase use of PD faster compared to large dialysis organizations and for-profit units, respectively.
Implementation of the Centers for Medicare and Medicaid Services ESRD payment reform was associated with an increased use of PD in the 2 years after PPS. Our findings highlight the role of financial incentives in changing practice patterns to increase use of a dialysis modality considered to be both more cost-effective and empowering to ESRD patients. However, even after PPS, rates of PD use remain low among the dialysis population in the USA.
医疗保险和医疗补助服务中心于2011年1月实施的终末期肾病(ESRD)前瞻性支付系统(PPS),通过各种经济激励措施鼓励使用腹膜透析(PD)。我们的目标是确定PPS是否有效地增加了初治透析患者对PD的使用。
我们的研究使用美国肾脏数据系统(USRDS)识别了2009年至2012年间开始透析的430927名成年患者。采用中断时间序列法评估PPS与透析开始时PD使用之间的关联。我们进一步按患者人口统计学、透析前护理以及机构连锁和盈利状况进行分层。
中断时间序列分析表明,PPS与PPS实施后2年内PD使用增加相关(斜率变化 = 0.04,< 0.0001),尽管在PPS开始时PD使用水平没有立即变化( = 0.512)。分层分析表明,PPS导致所有年龄、种族和性别组的PD使用增加(< 0.05),尽管女性增加幅度较小( = 0.09)。值得注意的是,与大型透析机构和营利性单位相比,小型透析机构和非营利组织似乎分别更快地增加了PD的使用。
医疗保险和医疗补助服务中心ESRD支付改革的实施与PPS后2年内PD使用增加相关。我们的研究结果突出了经济激励措施在改变实践模式以增加使用一种被认为对ESRD患者更具成本效益且更能增强其能力的透析方式方面的作用。然而,即使在PPS之后,美国透析人群中PD的使用率仍然较低。